Infliximab for Injection
Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
The first infliximab biosimilar marketed in China
Infliximab for Injection (Reminton), a recombinant anti-TNF-alpha chimeric monoclonal antibody, was approved for marketing by the National Medical Products Administration (NMPA) on July 14, 2021. It is the first infliximab biosimilar marketed in China. Taking advantage of CHO cell expression system, Remin_x005f ton has been proved with good efficacy, better safety, and lower immunogenicity in clinical studies.
Indications:
Crohn's disease in adults and children over 6 years of age, stulizing Crohn's disease,
ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis.
Recommended reading
Related products
-
Quick View
Aliquam id quam elementum arcu eleifend
$44.00Add to cartAenean bibendum posuere neque, quis hendrerit libero ultrices lacinia. Vestibulum venenatis elit non bibendum pulvinar. In luctus urna sapien, posuere fermentum nunc tempus eget. Fusce hendrerit nec diam quis ornare. Duis auctor, libero in efficitur finibus, purus diam maximus est, et rhoncus sapien justo nec sem
-
Quick View
The Benefits of Roof Insulation: Is it a Wise Investment?
Read moreRoof insulation is a topic that often goes unnoticed, yet it plays a crucial role in maintaining a comfortable and energy-efficient home. Many homeowners wonder whether insulating their roof is a good idea. In this article, we will delve into the benefits of roof insulation, exploring its impact on energy efficiency, cost savings, and overall …
The Benefits of Roof Insulation: Is it a Wise Investment?Read More
-
Quick View
Suspendisse vehicula at dui
$56.00Add to cartMorbi mattis ipsum sem, in gravida dolor venenatis vestibulum. Aenean laoreet, nisi in bibendum dictum, purus libero accumsan enim, id vehicula enim metus vitae ipsum. Maecenas nulla est, dictum quis augue ultrices, dictum rutrum enim. Aliquam erat volutpat. Quisque ultricies ornare lacus, eu sagittis urna euismod ac. Nulla rhoncus ultrices ligula, id maximus ligula ultricies non.
-
Quick View
Mauris elit magna, aliquet
$50.00Add to cartFusce sagittis tellus eget ante gravida euismod. Mauris interdum, neque eu hendrerit aliquet, diam nisi fringilla nisi, at convallis ante velit sed erat. Vestibulum mollis lorem ut molestie pharetra. Sed pretium quam lacinia, placerat urna a, tincidunt massa. Mauris elit magna, aliquet blandit mauris eu
Reviews
There are no reviews yet.